Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2018

Jan 26, 2018

34129_dirs_2018-01-26_7f73a512-176a-4243-8d47-c2ad83f1054f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-01-24

Reporting Person: Risser Eric Blasius (Sr VP & Chief Business Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-01-24 Common Stock M 3000 $0.94 Acquired 12100 Direct
2018-01-24 Common Stock S 3000 $22.50 Disposed 9100 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-01-24 Employee stock option (right to buy) $0.94 M 3000 Disposed 2019-03-23 Common Stock (3000.0) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted 11/14/17.

F2: The Form 4, as originally filed on 1/25/18, incorrectly reported the sale price. The Form 4, as amended by this Form 4/A, correctly reports such information.

F3: The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $22.50 to $22.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.